Metformin episodes of hyperglycemia. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Islets of Langerhans Insulin-Secreting Cells Liver Venoms Cells, Cultured

Organisms4

Rats, Wistar Rats, Sprague-Dawley Rats, Zucker Mice, Inbred C57BL

Diseases24

Hyperglycemia Diabetes Mellitus, Type 2 Diabetes Mellitus, Experimental Diabetes Mellitus Polycystic Ovary Syndrome Insulin Resistance Hypoglycemia Acidosis, Lactic Hyperinsulinism Diabetes Mellitus, Type 1 Diabetes Complications Diabetic Angiopathies Glucose Intolerance Body Weight Obesity Glycosuria Disease Models, Animal Prediabetic State Diabetic Nephropathies Acute Disease Diabetic Ketoacidosis Hyperglycemic Hyperosmolar Nonketotic Coma Diabetes, Gestational Pregnancy in Diabetics

Chemicals and Drugs37

Metformin Hypoglycemic Agents Blood Glucose Insulin Glucose Sulfonylurea Compounds Hemoglobin A, Glycosylated AMP-Activated Protein Kinases Streptozocin Thiazolidinediones Phenformin Glucagon Glipizide Adenylate Kinase Clomiphene C-Peptide Fertility Agents, Female Dipeptidyl-Peptidase IV Inhibitors Glucagon-Like Peptide 1 Aminoimidazole Carboxamide Phlorhizin Insulin, Long-Acting Glucokinase Adamantane Fructosamine Alloxan Placebos Organic Cation Transport Proteins Venoms Ribonucleotides Fatty Acids, Nonesterified Acarbose Glyburide Triglycerides Deoxyglucose Sodium-Glucose Transporter 2 Lactates

Analytical, Diagnostic and Therapeutic Techniques and Equipment15

Diabetes Mellitus, Experimental Episode of Care Glucose Tolerance Test Treatment Outcome Body Weight Glucose Clamp Technique Drug Therapy, Combination Obesity Risk Factors Disease Models, Animal Retrospective Studies Prospective Studies Double-Blind Method Placebos Administration, Oral

Psychiatry and Psychology1

Phenomena and Processes11

Insulin Resistance Fasting Time Factors Gluconeogenesis Postprandial Period Body Weight Obesity Dose-Response Relationship, Drug Oxidative Stress Signal Transduction Pregnancy

Health Care6

Episode of Care Treatment Outcome Risk Factors Retrospective Studies Prospective Studies Double-Blind Method

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Health Care

Metformin Hyperglycemia Hypoglycemic Agents Blood Glucose Diabetes Mellitus, Type 2 Insulin Diabetes Mellitus, Experimental Glucose Sulfonylurea Compounds Episode of Care Hemoglobin A, Glycosylated Diabetes Mellitus AMP-Activated Protein Kinases Glucose Tolerance Test Polycystic Ovary Syndrome Insulin Resistance Streptozocin Hypoglycemia Thiazolidinediones Phenformin Acidosis, Lactic Hyperinsulinism Diabetes Mellitus, Type 1 Fasting Time Factors Islets of Langerhans Gluconeogenesis Glucagon Insulin-Secreting Cells Glipizide Diabetes Complications Adenylate Kinase Diabetic Angiopathies Glucose Intolerance Treatment Outcome Postprandial Period Body Weight Glucose Clamp Technique Drug Therapy, Combination Clomiphene C-Peptide Obesity Fertility Agents, Female Dipeptidyl-Peptidase IV Inhibitors Liver Glycosuria Glucagon-Like Peptide 1 Rats, Wistar Risk Factors Aminoimidazole Carboxamide Rats, Sprague-Dawley Disease Models, Animal Prediabetic State Rats, Zucker Phlorhizin Insulin, Long-Acting Retrospective Studies Glucokinase Adamantane Diabetic Nephropathies Dose-Response Relationship, Drug Prospective Studies Fructosamine Double-Blind Method Mice, Inbred C57BL Alloxan Acute Disease Diabetic Ketoacidosis Placebos Organic Cation Transport Proteins Venoms Hyperglycemic Hyperosmolar Nonketotic Coma Diabetes, Gestational Oxidative Stress Ribonucleotides Fatty Acids, Nonesterified Pregnancy in Diabetics Administration, Oral Signal Transduction Acarbose Cells, Cultured Glyburide Pregnancy Triglycerides Deoxyglucose Sodium-Glucose Transporter 2 Lactates

No FAQ available that match "metformin episodes of hyperglycemia"